Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. able

ABLE SIGNED

Home use, affordable and lightweight exoskeleton for people with lower-limb paralysis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 ABLE project word cloud

Explore the words cloud of the ABLE project. It provides you a very rough idea of what is the project "ABLE" about.

upc    walk    validate    human    150    company    self    egrave    injury    lightweight    affordable    boosting    walking    accelerator    professional    palliating    business    leg    polit    mobility    stakeholders    18    fit    patient    won    home    helps    algorithms    start    restore    sensor    programs    detects    launch    patented    caused    centers    heavy    restores    team    usa    spin    paralysis    exoskeleton    intention    vision    acceleration    exoskeletons    movement    boston    healthcare    catalunya    actuator    richi    foundation    innovative    intuitive    again    people    successful    eit    ups    extends    limb    confidence    robotic    supervision    medical    universitat    off    electric    establishing    model    allowed    trl9    caixaimpulse    independently    sedentary    movements    device    move    readiness    plan    medtech    found    massmedic    mimicking    independence    hospitals    rehabilitation    world    had    de    disruptive    commercialize    market    lifestyle    everybody    newly    motion    lower    expensive    possibility    cnica    assist    awarded    cimit    timeframe    health    trained    inertial    first    flexes    trl    natural   

Project "ABLE" data sheet

The following table provides information about the project.

Coordinator		 ABLE HUMAN MOTION S.L. 

Organization address
address: SANT EUDALD 57 1 1
city: Barcelona
postcode: 8023
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Spain [ES]
 Project website http://www.ablehumanmotion.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ABLE HUMAN MOTION S.L. ES (Barcelona) coordinator 50˙000.00

Map

 Project objective

People with lower-limb paralysis could walk again if they had a robotic exoskeleton to restore the leg movements affected by the injury. However, current devices are expensive (cost about 100 k€), heavy and require trained professional supervision. Therefore, they are only found in large hospitals and rehabilitation centers, and are out of the reach of the patient.

ABLE Human Motion is a medical device spin-off from Universitat Politècnica de Catalunya (UPC) that is developing and will commercialize robotic exoskeletons to enhance their mobility and independence. ABLE’s vision is to build a world where everybody has the possibility to move independently, with that aim we plan the launch of ABLE: the first home use, affordable and lightweight exoskeleton that restores the ability to walk of people with lower-limb paralysis in a natural and intuitive way. It is based on an electric actuator that flexes and extends the leg mimicking human natural movement, and an inertial sensor that together with dedicated algorithms detects the user’s intention to make the step forward. This patented and disruptive system to assist walking helps palliating health issues caused by sedentary lifestyle while boosting self-confidence and independence.

So far our newly established company has been awarded as an innovative technology to improve healthcare by CaixaImpulse and EIT Health. We have been selected among the 5 most promising medtech start-ups by MassMEDIC (Boston, USA). The team has also won the acceleration programs organized by Richi Foundation and CIMIT, the most successful health accelerator in the world. This has allowed us to validate the product-market fit with more than 150 stakeholders, establishing a viable business model and a go-to-market plan.

The project is currently at Technology Readiness Level (TRL) between 6 and 7, and should reach TRL9 within an 18-month timeframe.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ABLE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ABLE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More